Alnylam Pharmaceuticals Operating Expenses 2010-2024 | ALNY
Alnylam Pharmaceuticals operating expenses for the twelve months ending June 30, 2024 were $2.242B, a 8.63% increase year-over-year.
- Alnylam Pharmaceuticals annual operating expenses for 2023 were $2.11B, a 15.8% increase from 2022.
- Alnylam Pharmaceuticals annual operating expenses for 2022 were $1.822B, a 17.36% increase from 2021.
- Alnylam Pharmaceuticals annual operating expenses for 2021 were $1.553B, a 17.53% increase from 2020.